Canada - English - Health Canada

pharmascience inc - fluorometholone - suspension - 0.1% - fluorometholone 0.1% - corticosteroids

United States - English - NLM (National Library of Medicine)

amneal pharmaceuticals ny llc - fluorometholone (unii: sv0csg527l) (fluorometholone - unii:sv0csg527l) - fluorometholone ophthalmic suspension is indicated for the treatment of corticosteroid-responsive inflammation of the palpebral and bulbar conjunctiva, cornea and anterior segment of the globe. fluorometholone ophthalmic suspension is contraindicated in most viral diseases of the cornea and conjunctiva, including epithelial herpes simplex keratitis (dendritic keratitis), vaccinia, and varicella, and also in mycobacterial infection of the eye, and fungal diseases of ocular structures. fluorometholone ophthalmic suspension is also contraindicated in individuals with known or suspected hypersensitivity to any of the ingredients of this preparation and to other corticosteroids.

Canada - English - Health Canada

sandoz canada incorporated - fluorometholone - suspension - 0.1% - fluorometholone 0.1% - corticosteroids

New Zealand - English - Medsafe (Medicines Safety Authority)

alcon laboratories australia pty ltd (nz) - fluorometholone acetate 1 mg/ml;   - eye drops, solution - 0.1 % - active: fluorometholone acetate 1 mg/ml   excipient: benzalkonium chloride disodium edetate dihydrate hydrochloric acid hyetellose monobasic sodium phosphate dihydrate purified water sodium chloride sodium hydroxide tyloxapol

New Zealand - English - Medsafe (Medicines Safety Authority)

alcon laboratories australia pty ltd (nz) - fluorometholone acetate 0.1%{relative} (+ 2% excess);  ; tobramycin 0.3%{relative} (+ 5% excess. (based on potency of 1mg potency/mg));   - eye drops, suspension - active: fluorometholone acetate 0.1%{relative} (+ 2% excess)   tobramycin 0.3%{relative} (+ 5% excess. (based on potency of 1mg potency/mg))   excipient: benzalkonium chloride disodium edetate dihydrate hyetellose purified water sodium chloride tyloxapol

Israel - English - Ministry of Health

abbvie biopharmaceuticals ltd, israel - fluorometholone - ophthalmic suspension - fluorometholone 0.1 %w/v - fluorometholone - fluorometholone - to treat eye inflammation.

Australia - English - Department of Health (Therapeutic Goods Administration)

alcon laboratories australia pty ltd - fluorometholone acetate -

Australia - English - Department of Health (Therapeutic Goods Administration)

abbvie pty ltd - fluorometholone, quantity: 1 mg/ml - eye drops, suspension - excipient ingredients: benzalkonium chloride; disodium edetate; sodium chloride; monobasic sodium phosphate; dibasic sodium phosphate heptahydrate; polysorbate 80; sodium hydroxide; purified water; polyvinyl alcohol - indications as at 23 oct 1995 : for steroid responsive inflammation of the palpebral and bulbar conjunctiva, cornea and anterior segment of the globe.

Japan - English - すりの適正使用協議会 RAD-AR Council, Japan

senju pharmaceutical co.,ltd. - fluorometholone - white ophthalmic suspension when shaken, (volume)5ml

Japan - English - すりの適正使用協議会 RAD-AR Council, Japan

wakamoto pharmaceutical co., ltd - fluorometholone - white or milky white ophthalmic suspension, (cap) pale pink